Together against Covid-19 pandemic
In these difficult times dominated by the Covid-19 pandemic, BioRN is taking actions to support the global life science community in our networking function. BioRN community - as one of the strongest life science networks in Europe, can strongly contribute to the fight against the SARS-CoV-2 virus.
Scroll down for current 'Offer' and 'Search' ads.
Please submit your contribution to info[at]biorn.org.
          Form-Together against Covid-19 Pandemic

OFFER

Dose finding for new vaccines and drugs, Clinical Trial Design (sample size calculations etc.), Translational PK/PD modelling, Analysis of large omics datasets.

Click on 'more'

SEARCH

Collaborators who are interested in partnering with EVI for the development of a Covid-19 vaccine.

 

 

Click on 'more'

OFFER

We help sponsors develop innovative adaptive study design with very rapid turn-around (24-48 hours), enabling fast review and regulatory engagements.

Click on 'more'

OFFER

Textile face masks, reusable, washable (min 85°C), OEKO-TEX certification.
Large quantities, min 50.000, 2€ (+VAT) per mask. Delivery within 2 weeks.

Click on 'more'

OFFER

Anti SARS CoV 2 ELISA E111 IVD: a highly specific enzyme immunoassay for the detection of antibodies against the SARS CoV 2 S1 receptor binding domain (RBD) in human blood.

Click on 'more'

SEARCH

COVID-19 antibody related products i.e. standalone antibodies, conjugated antibodies, COVID -19 antigens & recombinant proteins.

Click on 'more'

OFFER

Research product: PEPperCHIP® SARS CoV 2 Proteome Microarray

 

 

 

Click on 'more'
 

OFFER

Legal advice of any form with respect to current commercial/legal situation in crises as well as their R&D operations, relative to the CORONA pandemic or other.

Click on 'more'

OFFER

Recombinant SARS-CoV-2 proteins which can be used as antigen or control protein for analytic and diagnostic purposes as well as for vaccine development.

Click on 'more'

OFFER

Biomanufacturing technology and services for scaling up COVID-19 vaccine candidate production

Click on 'more'

OFFER

Analytical support for vaccine, gene therapy or antibody product development. 

 

Click on 'more'

OFFER

SARS-CoV-2 RNA purification and RT-PCR kits, NGS panels, recombinant proteins, antibodies, IgM/IgG detection kits, ELISA, compound libraries and antiviral agents.

Click on 'more'

SEARCH

We are looking to connect to biotechnology or pharmaceutical companies and research facilities who are involved in cancer & stem cell research and/or 3D cell culture.

Click on 'more'

OFFER

Development of an antiviral product based on gene therapy.

Click on 'more'

SEARCH

peripheral blood mononuclear cells and/or isolated T and B cell fractions patients and healthy controls.

Click on 'more'

SEARCH

Antibody against the human ACE2 Receptor for the characterization of a cell line

 

 

Click on 'more'

SEARCH

We are offering a grant comprising up to 250,000 €/year for 3 years. Proposals will be considered that leverage technological solutions to be prepared for pandemic outbreaks or to fight emerging viral infections.

OFFER

qPCR instrument (depending on urgency of the situation)

Coating of microtiter plates for Covid-19 immuno-assays (ELISA) 
Lab technicians (on voluntary basis)

Click on 'more'

OFFER

Multiplex protein profiling services for acceleration of COVID 19 research

Click on 'more'

OFFER

analytical and clinical performance evaluation for COVID-19 diagnostic kit

collection of Covid-19 patient samples

S2 contract lab

Click on 'more'

OFFER

Coronavirus S-protein pseudotyped lentivirus; Recombinant coronavirus vectors (25+ species); Cell line models for Corona-related research; Animal models for Corona-related research

Click on 'more'

OFFER

Broad coverage of metabolic pathways
Many immunomodulatory pathways analyzed
Quantitative and reproducible results
Innovative kit design

Click on 'more'

OFFER

Data analysis, on demand data reporting, statistical support, programming capacities in R and SAS

 

 

Click on 'more'

OFFER

fightCOVID@DKFZ, a collaboration among DKFZ, university hospitals in Heidelberg and Mannheim.

Prof. Dr. Ralf Bartenschlager​

Dr. Catherine Moreau

OFFER

To provide free label cloud software to organizations fighting COVID-19

 

 

Click on 'more'

SEARCH

Casein (fatty acid free, for blocking coated microtiter plates, currently supply is limited)

Click on 'more'

SEARCH

Academic groups or biotech/pharma companies working on anti SARS CoV 2 antibodies.

Click on 'more'

OFFER

A professional information search service  in the area of patents and literature around COVID 19, public-free data, public hidden-data and commercial available data

Click on 'more'

SEARCH

Clinical partners with relevant biological sample cohorts such as COVID-19 positive tested patients (acute phase and post-infection), preferably plasma/serum.

Click on 'more'

OFFER

Pragmatic and straight-forward IP advice at special rates regarding the protection of IP and contractual agreements needed to tackle the challenges of Covid-19 pandemic.

Click on 'more'

OFFER

Collagen Materials for cell culture
Cell culture facilities
Fluorescent microscopy
Molecular biology lab (including PCR)

 

Click on 'more'

FUNDING    I    GENERAL INFORMATION    I    WEBINARS

Nov 11th, 2019

BioRN Annual Conference 2019

The BioRN Annual Conference 2019 provided an overview on current and future application of artificial intelligence and machine learning contributing to improve health, at different stages.

January 31th, 2019

Labiotech Refresh

To meet some great people, to listen to some awesome speakers, and to enjoy some free beer.

Organised with Labiotech.

October 24th, 2017

BioRN Annual Conference 2017

The 2017 BioRN Annual Conference embraced our members’ and partners‘ technological diversity and collaboration potential.

Oct 21th, 2019

Technology Transfer – The International Perspective

Regional and international key opinion leaders discuss best-practice and new ideas in technology transfer.

October 25th, 2018

BioRN Annual Conference 2018

The two leading-edge life science clusters BioRN and Ci3 have joint forces to foster knowledge exchange in cancer immunotherapy.

September 27th, 2016

BioRN Annual Conference 2016

Since 2009, each year the BioRN Annual Conference has been a valuable source of top information, lively discussions and networking opportunities.

May 7-8th, 2019

LabVision 2019

BioRN organised the workshop "Smart Drug Discovery - The future is now!" at the LabVision 2019 organised by SPECTARIS.

September 25th, 2018

HAE Visionary Seminar

Health Axis Europe Visionary Seminar covered some of the most promising novel approaches in oncology research from Flemish and German academia and industry.

September 26th, 2016

European Health Science Match

Is it possible to explain a complex science in three minutes? In a location that usually hosts pop concerts? At the European Health Science Match, 100 speakers accepted the challenge.

CONTACT

BioRN Network e.V.

Im Neuenheimer Feld 582

D-69120 Heidelberg

Contact us >>

INFORMATION

BioRN is the science and industry cluster of the Rhine-Main-Neckar region around Heidelberg, one of Germany’s strongest biotech hubs. It is a non-profit network fostering health innovations, supporting a rich translational ecosystem and promoting, representing and connecting the regional innovation stakeholders.

  • LinkedIn Social Icon
  • Twitter Social Icon
  • YouTube Social  Icon
go-cluster-LOGO_RGB-WEB.jpg

"Making Life Science matter...

...and Innovation happen!"

cl_label_silber.png

© Copyright - BioRN Network e.V. -  Imprint & Legal Notice - Data Privacy Policy